Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?

Neurology. 2011 Apr 12;76(15):1362-3; author reply 1363. doi: 10.1212/WNL.0b013e318210e5d0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / chemically induced*
  • Natalizumab
  • Substance Withdrawal Syndrome*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab